Delivery Order SPE2DB20D7066-SPE2DB25FC4NB
- Not listed
- The Defense Logistics Agency awarded a $11,265.34 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product used in clinical settings. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a $6,378.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product. This non-set-aside, firm fixed-price contract is scheduled for completion by June 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at approximately $61,000 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a parenteral nutrition product. This competitive, firm fixed-price delivery order was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order valued at $5,895.94 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a parenteral nutrition product used in clinical healthcare settings. This firm fixed price, non-set-aside contract was executed on August 17, 2025, with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Infuvite Adult Vial 10ML, a pharmaceutical product used in clinical nutrition support. This firm fixed price delivery order has a ceiling value of $3,008.21 and is scheduled for completion by August 5, 2025. The award was competitively procured with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,793.37 for INFUVITE Adult Vial 10ML, a parenteral nutrition product used in clinical settings. This firm fixed-price delivery order, issued on August 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $4,999.10 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Infuvite Pediatric Vial 5ML, a pediatric intravenous nutritional supplement. This firm fixed-price delivery order, valued at $31,264.79, represents a non-set-aside competitive award and is set for ultimate completion by July 1, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This delivery order, valued at $5,810.46, was awarded to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product. The contract is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The Defense Logistics Agency, under the Department of Defense, funded this award. This delivery order was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Infuvite Pediatric Vial 5ML, a pediatric intravenous nutritional supplement. This firm fixed-price delivery order, valued at $2,245.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award is non-competitive and carries an ultimate completion date of August 14, 2025. AmerisourceBergen will perform...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4NBDelivery Order
The Defense Logistics Agency awarded a $1,499.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Infuvite Adult Vial 10ML, an intravenous nutritional supplement used in medical and military healthcare settings. This non-set-aside competitive award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this delivery order as a child contract under its larger prime indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp maintains a substantial $999.999 billion indefinite delivery vehicle (SPE2DX) with the Defense Logistics Agency that extends through December 2026, serving as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. Through this prime contract and associated delivery orders, the company supplies an extensive portfolio of pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capability to compete successfully in open competition across multiple therapeutic domains positions it as a key provider within the federal medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/26/25 |